Am J Transplant, Volume 21, Suppl 3 Archives - Page 48 of 139 - ATC Abstracts

2021 American Transplant Congress
Alemtuzumab vs Antithymocyte Globulin Induction in Hepatitis C Viremic Donors to Hepatis C Negative Kidney Transplant Recipients
K. Walter, L. Mincemoyer, J. Giang, J. Suero, N. Shah, K. Szempruch
University of North Carolina Medical Center, Chapel Hill, NC
*Purpose: The optimal induction agent for kidney transplantation of hepatitis C virus nucleic acid test positive donors to negative recipients (HCV NAT D+/R-) is unknown.…
2021 American Transplant Congress
Kidney Transplant Outcomes Stratified by Age with a Calcineurin and Steroid Free Regimen
R. Scalzo¹, M. Harris¹, J. Morris², J. Byrns¹
¹Pharmacy, Duke University Hospital, Durham, NC, ²Nephrology, Duke University Hospital, Durham, NC
*Purpose: To evaluate the impact of an alemtuzumab, belatacept, and sirolimus based regimen on renal function stratified by age in kidney transplant (KT) patients.*Methods: This…
2021 American Transplant Congress
Seasonal and Income-related Factors in Live Kidney Donation in the United States from 1995 to 2019
F. Al Ammary¹, A. Arking², G. Kaddu², J. Garonzik Wang², A. B. Massie², D. Segev², A. Muzaale²
¹Medicine, Johns Hopkins University, Baltimore, MD, ²Surgery, Johns Hopkins University, Baltimore, MD
*Purpose: For nearly two decades, the annual number of US live kidney donors has been characterized by striking and worrying patterns of general decline that…
2021 American Transplant Congress
Implementation of the Kidney Team at Home Intervention: Evaluating Generalizability, Implementation Process, and Effects
S. Redeker¹, S. Ismail¹, R. Timman¹, J. van Busschbach¹, C. Boonstra², H. F. Brulez³, D. A. Hollander⁴, L. Hilbrands⁵, F. J. Bemelman⁶, S. P. Berger⁷, J. van der Wetering⁸, R. A. van den Dorpel⁹, M. A. Jansen-Dekker¹⁰, W. Weimar⁸, E. K. Massey⁸
¹Psychiatry, Erasmus MC, Rotterdam, Netherlands, ²De Viersprong, Rotterdam, Netherlands, ³Internal Medicine, OLVG, Amsterdam, Netherlands, ⁴Internal Medicine, JBZ, Den Bosch, Netherlands, ⁵Internal Medicine, Radboud UMC, Nijmegen, Netherlands, ⁶Internal Medicine, Amsterdam UMC, Amsterdam, Netherlands, ⁷Internal Medicine, UMCG, Groningen, Netherlands, ⁸Internal Medicine, Erasmus MC, Rotterdam, Netherlands, ⁹Internal Medicine, Maasstad Ziekenhuis, Rotterdam, Netherlands, ¹⁰Internal Medicine, ZGT, Almelo, Netherlands
*Purpose: Research has shown that a home-based educational intervention for patients with chronic kidney disease results in better knowledge and communication on all treatment options,…
2021 American Transplant Congress
Application of Incisional Wound Vac to Decrease Wound Complications and Surgical Site Infections: A Single Center Pilot Project
E. K. Venniro, M. Dokus, J. Taylor, R. Kashyap
University of Rochester Medical Center, Rochester, NY
*Purpose: Wound complications and surgical site infections (SSIs) are common but morbid complications of transplant in immunosuppressed patients. Kidney transplant patients who are obese, highly…
2021 American Transplant Congress
Longitudinal Studies of Blood Anellovirus DNA Prior to Acute Rejection or Major Infection Events in Pediatric Kidney Transplant Recipients (PKTx)
R. Dandamudi, H. Gu, C. Goss, H. Gula, K. Wylie, V. Dharnidharka
Washington University in St Louis, St. Louis, MO
*Purpose: Blood levels of the ubiquitous but non-pathogenic anellovirus (AnV) taxa have been postulated to represent a biomarker of the overall state of immunosuppression after…
2021 American Transplant Congress
Use of Donor-Derived Cell-Free DNA in Children with Kidney Transplantation: A Pilot Study
E. Winnicki, J. Brennan, M. McEnhill, P. Brakeman, E. Ku
UCSF, San Francisco, CA
*Purpose: Use of a blood test to detect donor-derived cell-free DNA (dd-cfDNA) levels has been shown to predict rejection in adults with kidney transplants. If…
2021 American Transplant Congress
Donor Derived Cell Free Dna: Teasing Out the Optimal Threshold for Antibody Mediated Rejection
M. Mattu¹, H. Murad¹, M. Merzkani¹, A. Malone¹, R. Delos Santos¹, M. Wang², B. Wang², S. Chang², T. Alhamad¹
¹Department of Medicine, Washington University in St Louis, St Louis, MO, ²Washington University in St Louis, St Louis, MO
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) assay is a putative noninvasive marker for renal allograft rejection and other etiologies of injury such as BK nephropathy. The…
2021 American Transplant Congress
Belatacept Conversion in Proteinuric Renal Transplant Recipients: An Interventional Multi-Center Trial
O. Efe¹, A. Al Jurdi¹, D. Wojciechowski², K. Safa¹, H. Gilligan¹, A. Chandraker³, J. Azzi³, A. Weins³, L. V. Riella¹
¹Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, ²UT Southwestern Medical Center, Dallas, TX, ³Brigham and Women’s Hospital, Boston, MA
*Purpose: Proteinuria develops in about 30% of kidney transplant recipients and is a strong predictor of graft loss. ACEis/ARBs can reduce proteinuria but are frequently…
2021 American Transplant Congress
The Importance of Persistent and Recurrent T Cell Mediated Rejection in Tacrolimus Treated Renal Transplant Recipients
C. Rampersad¹, I. W. Gibson², D. N. Rush¹, D. Pochinco³, P. E. Birk⁴, A. Goldberg⁴, T. Blydt-Hansen⁵, M. Karpinski¹, J. Shaw¹, J. Ho¹, P. W. Nickerson¹, C. Wiebe¹
¹Department of Medicine, University of Manitoba, Winnipeg, MB, Canada, ²Department of Pathology, University of Manitoba, Winnipeg, MB, Canada, ³Shared Health Services Manitoba, Winnipeg, MB, Canada, ⁴Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada, ⁵Department of Pediatrics, University of British Columbia, Winnipeg, MB, Canada
*Purpose: Optimal follow-up after treatment for T-cell mediated rejection (TCMR) is not well-established. We sought to identify the prevalence and clinical associations of repeated TCMR…